The month-of-birth pattern in narcolepsy is moderated by cataplexy severity and may be independent of HLA-DQB1*0602

Sleep. 2004 Dec 15;27(8):1471-5. doi: 10.1093/sleep/27.8.1471.

Abstract

Objectives: A March peak and a September trough in the birth pattern of narcolepsy patients with clear-cut cataplexy was recently reported. The objectives of the present study were to determine whether the month-of-birth pattern would (a) vary with the presence and severity of cataplexy and (b) differ for patients positive and negative for HLA-DQB1*0602.

Design: Cross-sectional survey with data obtained from the clinical trials assessing the safety and efficacy of modafinil in the treatment of narcolepsy.

Setting: Sleep clinics throughout the United States.

Patients: A group of 530 narcolepsy patients diagnosed based on the International Classification of Sleep Disorders using clinical histories, nocturnal polysomnography, and Multiple Sleep Latency Tests.

Interventions: NA.

Measurements and results: A surplus of March births and a fall-off in September births was found in narcolepsy relative to the general population. This finding was only observed when cataplexy was moderate or severe. The month-of-birth pattern was similar for HLA-DQB1*0602 positive and negative patients. A March birth and HLA-DQB1*0602 positivity were independent risk factors in a logistic regression analysis.

Conclusions: Environmental events during development may influence narcolepsy severity or the likelihood of developing the disease.

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Benzhydryl Compounds / therapeutic use
  • Brain / metabolism
  • Cataplexy / drug therapy
  • Cataplexy / epidemiology
  • Cataplexy / genetics
  • Central Nervous System Stimulants / therapeutic use
  • Cross-Sectional Studies
  • Environment
  • Female
  • Genotype
  • HLA-DQ Antigens / genetics*
  • HLA-DQ beta-Chains
  • Humans
  • Incidence
  • Male
  • Mass Screening / methods
  • Membrane Glycoproteins / genetics*
  • Modafinil
  • Narcolepsy / drug therapy
  • Narcolepsy / epidemiology*
  • Narcolepsy / genetics*
  • Polysomnography
  • Seasons*
  • Severity of Illness Index
  • Sleep, REM / physiology
  • United States / epidemiology

Substances

  • Benzhydryl Compounds
  • Central Nervous System Stimulants
  • HLA-DQ Antigens
  • HLA-DQ beta-Chains
  • HLA-DQB1 antigen
  • Membrane Glycoproteins
  • Modafinil